David Geffen School of Medicine at UCLA

UCLA Study: Advanced MRI and Focal Therapy Revolutionize Prostate Cancer Surveillance

- A groundbreaking UCLA study demonstrates that combining advanced MRI imaging with targeted focal therapy allows men with low to intermediate-risk prostate cancer to safely remain on active surveillance longer. - The research found that 84% of men receiving focal therapy avoided radical treatments like surgery or radiation, compared to only 46% in the control group, significantly reducing overtreatment risks. - MRI technology proved remarkably accurate, correctly predicting disease stability in 90-95% of low-risk cases and 70% of intermediate-risk cases, while reducing the need for invasive repeat biopsies.